Review Article – Nanomedicine-Based Approaches for mRNA Delivery

Review Article

Nanomedicine-Based Approaches for mRNA Delivery

Author Name: - Miss. Misal Puja Balasaheb*1

Co-author Name: - Mr. Wamane Vikas Bhausaheb*2

*1 Student, Pratibhatai Pawar College of Pharmacy, Wadala Mahadev.

*2 Assistant professor, Pratibhatai Pawar College of Pharmacy, Wadala Mahadev.

Abstract:

             Messenger RNA (mRNA) has immense potential for developing a wide range of therapies, including immunotherapy and protein replacement. As mRNA presents no risk of integration into the host genome and does not require nuclear entry for transfection, which allows protein production even in nondividing cells, mRNA-based approaches can be envisioned as safe and practical therapeutic strategies. Nevertheless, mRNA presents unfavorable characteristics, such as large size, immunogenicity, limited cellular uptake, and sensitivity to enzymatic degradation, which hinder its use as a therapeutic agent. While mRNA stability and immunogenicity have been ameliorated by direct modifications on the mRNA structure, further improvements in mRNA delivery are still needed for promoting its activity in biological settings. In this regard, nanomedicine has shown the ability for spatiotemporally controlling the function of a myriad of bioactive agents in vivo. Direct engineering of nanomedicine structures for loading, protecting, and releasing mRNA and navigating in biological environments can then be applied for promoting mRNA translation toward the development of effective treatments. Here, we review recent approaches aimed at enhancing mRNA function and its delivery through nanomedicines, with particular emphasis on their applications and eventual clinical translation.

Keyword: mRNA delivery, mRNA engineering, Immunology